BNP Paribas Financial Markets’s Sanofi Contingent Value Rights GCVRZ Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-5,455
| Closed | -$4.69K | – | 4584 |
|
|
2019
Q4 | $4.69K | Hold |
5,455
| – | – | ﹤0.01% | 4192 |
|
|
2019
Q3 | $3.06K | Hold |
5,455
| – | – | ﹤0.01% | 4325 |
|
|
2019
Q2 | $2.84K | Hold |
5,455
| – | – | ﹤0.01% | 4291 |
|
|
2019
Q1 | $2.46K | Hold |
5,455
| – | – | ﹤0.01% | 4109 |
|
|
2018
Q4 | $2.62K | Hold |
5,455
| – | – | ﹤0.01% | 3748 |
|
|
2018
Q3 | $2.89K | Hold |
5,455
| – | – | ﹤0.01% | 4205 |
|
|
2018
Q2 | $2.73K | Hold |
5,455
| – | – | ﹤0.01% | 4218 |
|
|
2018
Q1 | $2.3K | Hold |
5,455
| – | – | ﹤0.01% | 4089 |
|
|
2017
Q4 | $2.07K | Hold |
5,455
| – | – | ﹤0.01% | 4082 |
|
|
2017
Q3 | $1.96K | Hold |
5,455
| – | – | ﹤0.01% | 4066 |
|
|
2017
Q2 | $2.07K | Hold |
5,455
| – | – | ﹤0.01% | 4086 |
|
|
2017
Q1 | $2.46K | Hold |
5,455
| – | – | ﹤0.01% | 3487 |
|
|
2016
Q4 | $2.07K | Hold |
5,455
| – | – | ﹤0.01% | 3910 |
|
|
2016
Q3 | $1.47K | Hold |
5,455
| – | – | ﹤0.01% | 3465 |
|
|
2016
Q2 | $1.31K | Hold |
5,455
| – | – | ﹤0.01% | 3470 |
|
|
2016
Q1 | $600 | Sell |
5,455
-5,455
| -50% | -$591 | ﹤0.01% | 2544 |
|
|
2015
Q4 | $1.2K | Buy |
10,910
+5,455
| +100% | +$770 | ﹤0.01% | 3506 |
|
|
2015
Q3 | $1.04K | Hold |
5,455
| – | – | ﹤0.01% | 3545 |
|
|
2015
Q2 | $3.82K | Sell |
5,455
-1,044
| -16% | -$722 | ﹤0.01% | 3453 |
|
|
2015
Q1 | $4.42K | Hold |
6,499
| – | – | ﹤0.01% | 3220 |
|
|
2014
Q4 | $5.13K | Hold |
6,499
| – | – | ﹤0.01% | 1816 |
|
|
2014
Q3 | $2.99K | Hold |
6,499
| – | – | ﹤0.01% | 3900 |
|
|
2014
Q2 | $3.25K | Hold |
6,499
| – | – | ﹤0.01% | 2835 |
|
|
2014
Q1 | $3.12K | Hold |
6,499
| – | – | ﹤0.01% | 2535 |
|
|
2013
Q4 | $2.21K | Sell |
6,499
-80,000
| -92% | -$96.7K | ﹤0.01% | 3616 |
|
|
2013
Q3 | $175K | Buy |
86,499
+37,536
| +77% | +$71.5K | ﹤0.01% | 2298 |
|
|
2013
Q2 | $93K | Buy |
+48,963
| New | +$86K | ﹤0.01% | 2548 |
|
BNP Paribas Financial Markets's GCVRZ Position: Q1 2020 in Review
BNP Paribas Financial Markets sold out of Sanofi Contingent Value Rights (GCVRZ) in Q1 2020, closing a stake of 5,455 shares — an estimated $4.69K sold.
BNP Paribas Financial Markets first reported a position in GCVRZ in Q2 2013 and held it in 27 quarters. The position peaked at $175K in Q3 2013. 2 funds tracked by Wall St. Rank hold GCVRZ as of Q1 2020.
- BNP Paribas Financial Markets reported no remaining Sanofi Contingent Value Rights position as of Q1 2020 after selling out during the quarter.
- BNP Paribas Financial Markets sold 5,455 Sanofi Contingent Value Rights shares in Q1 2020, an estimated $4.69K.
- BNP Paribas Financial Markets first reported a position in Sanofi Contingent Value Rights in Q2 2013 and held it in 27 quarters.
- BNP Paribas Financial Markets's Sanofi Contingent Value Rights position peaked at $175K in Q3 2013.
- 2 funds tracked by Wall St. Rank held Sanofi Contingent Value Rights as of Q1 2020.
Based on BNP Paribas Financial Markets's 13F filing for Q1 2020, filed 13 May 2020.